As of 2025-10-14, the Relative Valuation of Knight Therapeutics Inc (GUD.TO) is 0.54 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 5.77 CAD, the upside of Knight Therapeutics Inc based on Relative Valuation is -90.6%.
The range of the Relative Valuation is 0.02 - 2.00 CAD.
| Range | Selected | |
| Trailing P/E multiples | 5.8x - 306.0x | 7.2x |
| Forward P/E multiples | 9.0x - 21.2x | 11.2x |
| Fair Price | 0.02 - 2.00 | 0.54 |
| Upside | -99.6% - -65.4% | -90.6% |
| Date | P/E |
| 2025-10-10 | 1,501.25 |
| 2025-10-09 | 1,532.48 |
| 2025-10-08 | 1,527.27 |
| 2025-10-07 | 1,522.07 |
| 2025-10-06 | 1,537.68 |
| 2025-10-03 | 1,522.07 |
| 2025-10-02 | 1,516.87 |
| 2025-10-01 | 1,542.88 |
| 2025-09-30 | 1,529.87 |
| 2025-09-29 | 1,540.28 |
| 2025-09-26 | 1,542.88 |
| 2025-09-25 | 1,581.91 |
| 2025-09-24 | 1,579.31 |
| 2025-09-23 | 1,571.50 |
| 2025-09-22 | 1,607.93 |
| 2025-09-19 | 1,620.94 |
| 2025-09-18 | 1,613.13 |
| 2025-09-17 | 1,620.94 |
| 2025-09-16 | 1,639.15 |
| 2025-09-15 | 1,652.16 |
| 2025-09-12 | 1,649.56 |
| 2025-09-11 | 1,672.98 |
| 2025-09-10 | 1,665.17 |
| 2025-09-09 | 1,672.98 |
| 2025-09-08 | 1,678.18 |
| 2025-09-05 | 1,675.58 |
| 2025-09-04 | 1,675.58 |
| 2025-09-03 | 1,683.38 |
| 2025-09-02 | 1,678.18 |
| 2025-08-29 | 1,691.19 |
| 2025-08-28 | 1,665.17 |
| 2025-08-27 | 1,688.59 |
| 2025-08-26 | 1,691.19 |
| 2025-08-25 | 1,701.60 |
| 2025-08-22 | 1,678.18 |
| 2025-08-21 | 1,657.36 |
| 2025-08-20 | 1,667.77 |
| 2025-08-19 | 1,662.57 |
| 2025-08-18 | 1,639.15 |
| 2025-08-15 | 1,618.34 |
| 2025-08-14 | 1,626.14 |
| 2025-08-13 | 1,652.16 |
| 2025-08-12 | 1,670.37 |
| 2025-08-11 | 1,688.59 |
| 2025-08-08 | 1,646.96 |
| 2025-08-07 | 1,665.17 |
| 2025-08-06 | 1,636.55 |
| 2025-08-05 | 1,631.35 |
| 2025-08-01 | 1,605.33 |
| 2025-07-31 | 1,584.51 |